產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時(shí)服務(wù)熱線
ACHN (人腎細(xì)胞腺癌細(xì)胞) (STR鑒定正確)
貨號(hào)：CL-0021
規(guī)格：1×10?cells/T25培養(yǎng)瓶
價(jià)格： ￥1600
生長(zhǎng)培養(yǎng)基：MEM（含NEAA）＋10% FBS＋1% P/S
產(chǎn)品概述
| 名稱 | ACHN (人腎細(xì)胞腺癌細(xì)胞) (STR鑒定正確) |
| 種屬 | 人 |
| 生長(zhǎng)特性 | 貼壁細(xì)胞 |
| 細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
| 凍存條件 | 凍存液：55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認(rèn)） |
生長(zhǎng)培養(yǎng)基:
培養(yǎng)條件:
氣相：空氣，95%；CO2，5%, 溫度：37℃
|
| 推薦傳代比例 | 1:2-1:4 |
| 推薦換液頻率 | 2-3次/周 |
| 背景描述 | 人干擾素可抑制ACHN細(xì)胞生長(zhǎng)；ACHN細(xì)胞能用于人干擾素、干擾素誘導(dǎo)因子的抗腫瘤活性研究。 |
| 年齡（性別） | 男性；22歲 |
| 組織來(lái)源 | 腎細(xì)胞腺癌，胸水轉(zhuǎn)移灶 |
| 細(xì)胞類型 | 腫瘤細(xì)胞 |
| 腫瘤類型 | 腎癌細(xì)胞 |
| 生物安全等級(jí) | BSL-1 |
| 倍增時(shí)間 | ~28-36 hours |
| 致瘤性 | Yes, in nude mice (Tumors developed within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 1×10^7 cells). |
| 保藏機(jī)構(gòu) | ATCC; CRL-1611 ECACC; 88100508 |
STR鑒定
-
STR位點(diǎn)信息
Amelogenin X CSF1PO 11 D2S1338 17 D3S1358 17 D5S818 12 D7S820 9,11 D8S1179 12 D13S317 12 D16S539 12,13 D18S51 16 D19S433 14,15 D21S11 30 FGA 22 PentaD 12 PentaE 16 TH01 8 TPOX 8,11 vWA 16,17 D6S1043 11 D12S391 19,22 D2S441 11,14 -
STR鑒定圖
-
參考文獻(xiàn)
-
The RBPJ/DAPK3/UBE3A signaling axis induces PBRM1 degradation to modulate the sensitivity of renal cell carcinoma to CDK4/6 inhibitors(2022/04/02)
作者：Liu Wentao, Zhang Bin, Zhang Dan
期刊：Cell Death & Disease
DOI：10.1038/s41419-022-04760-6
影響因子 ：9.000
引用產(chǎn)品：CL-0005 CL-0010 CL-0021 PB180120 PM150110 PM150210 PM150410
-
TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3(2024/05/22)
作者：Qi Zhang, Yong Li, Qing Zhu
期刊：Cell Death & Disease
DOI：10.1038/s41419-024-06741-3
影響因子 ：9.000
引用產(chǎn)品：CL-0021
-
Serine hydroxymethyltransferase 2 knockdown induces apoptosis in ccRCC by causing lysosomal membrane permeabilization via metabolic reprogramming(2023/02/20)
作者：Zhangnan Liu, Mengzhen Fan, Junqing Hou
期刊：Cell Death & Disease
DOI：10.1038/s41419-023-05677-4
影響因子 ：9.000
-
Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer(2022/11/17)
作者：Ren, Jiannan, Yu, Haixin, Li, Wei, Jin, Xin, Yan, Bin
期刊：BRITISH JOURNAL OF CANCER
DOI：10.1038/s41416-022-02058-0
影響因子 ：8.800
-
Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma(2022/09/30)
作者：Liangmin Fu, Jiahao Bao, Jinhui Li
期刊：Frontiers in Immunology
DOI：10.3389/fimmu.2022.1021935
影響因子 ：8.786
引用產(chǎn)品：CL-0021
-
Prognostic and tumor microenvironmental feature of clear cell renal cell carcinoma revealed by m6A and lactylation modification-related genes(2023/08/11)
作者：Lin Yang, Xiaoyu Wang, Jiahao Liu
期刊：Frontiers in Immunology
DOI：10.3389/fimmu.2023.1225023
影響因子 ：7.300
-
Nanobody-loaded nanobubbles targeting G250 antigen with ultrasound/photoacoustic/fluorescence multimodal imaging capabilities for specifically enhanced imaging of RCC(2023/11/20)
作者：Jiajiu Chen, Jingyi Li, Chengjie Zhong
期刊：Nanoscale
影響因子 ：6.700
引用產(chǎn)品：CL-0021
-
Selective expansion of renal cancer stem cells using microfluidic single-cell culture arrays for anticancer drug testing(2024/02/01)
作者：Xiaogang Wang, Tao He, Zihe Chen
期刊：LAB ON A CHIP
影響因子 ：6.100
引用產(chǎn)品：CL-0021
-
RETRACTED ARTICLE: Silencing circular RNA-ZNF652 represses proliferation and EMT process of renal carcinoma cells via raising miR-205(2020/2/19)
作者：Ludong Zhang, Ya Guo
期刊：Artificial Cells Nanomedicine and Biotechnology
DOI：10.1080/21691401.2020.1725532
影響因子 ：5.800
-
HOXD8 suppresses renal cell carcinoma growth by upregulating SHMT1 expression(2023/09/26)
作者：Yang Yang, Minghui Zhang, Yaxuan Zhao
期刊：CANCER SCIENCE
影響因子 ：5.700
-
Identification of molecular subtypes and diagnostic model in clear cell renal cell carcinoma based on collagen-related genes may predict the response of immunotherapy(2024/02/05)
作者：Yulong Hong, Zhengtong Lv, Zhuo Xing
期刊：Frontiers in Pharmacology
DOI：10.3389/fphar.2024.1325447
影響因子 ：5.600
引用產(chǎn)品：CL-0021
-
High-fat diet alters immune cells in spleen, kidney and tumor and impacts the volume growth of renal cell carcinoma(2023/10/18)
作者：Zirun Zheng, Ke Ma, Hongyue Li
期刊：INTERNATIONAL IMMUNOPHARMACOLOGY
DOI：10.1016/j.intimp.2023.110982
影響因子 ：5.600
引用產(chǎn)品：CL-0021
-
Root extract of Hemsleya amabilis Diels suppresses renal cell carcinoma cell growth through inducing apoptosis and G2/M phase arrest via PI3K/AKT signaling pathway activation(2023/08/07)
作者：Kai Li, Ganhua You, Kehua Jiang, Rongpin Wang, Wuchao Li, Yonglu Meng, Yinyi Fang, Weiming Chen, Guohua Zhu, Jukun Song, Wei Wang, Hao Su, Bin Hu, Fa Sun, Zhenyu Jia, Can Li, Jianguo Zhu
期刊：JOURNAL OF ETHNOPHARMACOLOGY
影響因子 ：5.400
-
The mechanism of long-chain acyl-CoA synthetase 3 in inhibiting cell proliferation, migration, and invasion in clear cell renal cell carcinoma(2023/03/15)
作者：Lin Zhang, Bo Wu, Dongwen Wang
期刊：American Journal of Cancer Research
DOI：PMID:37034217
影響因子 ：5.300
引用產(chǎn)品：CL-0005 CL-0009 CL-0010 CL-0021 PM150110 PM150411
-
Disulfideptosis-associated lncRNAs reveal features of prognostic, immune escape, tumor mutation, and tumor malignant progression in renal clear cell carcinoma(2024/02/08)
作者：Xungang Li, Xinxi Deng, Taobin Liu
期刊：Aging-US
影響因子 ：5.200
引用產(chǎn)品：CL-0021
-
LncRNA-encoded Micropeptide ACLY?-?BP drives lipid deposition and cell proliferation in Clear Cell Renal Cell Carcinoma via maintenance of ACLY acetylation(2023/07/06)
作者：Shenghua Zhang, Zheng Zhang, Xiaolong Liu
期刊：MOLECULAR CANCER RESEARCH
DOI：10.1158/1541-7786.MCR-22-0781
影響因子 ：5.200
-
TFE3-SLC36A1 axis promotes resistance to glucose starvation in kidney cancer cells(2024/04/08)
作者：Suli Lv, Zongbiao Zhang, Zhenyong Li
期刊：JOURNAL OF BIOLOGICAL CHEMISTRY
影響因子 ：4.800
引用產(chǎn)品：CL-0021
-
Low ACADM expression predicts poor prognosis and suppressive tumor microenvironment in clear cell renal cell carcinoma(2024/04/25)
作者：Libin Zhou, Min Yin, Fei Guo
期刊：Scientific Reports
DOI：10.1038/s41598-024-59746-5
影響因子 ：4.600
引用產(chǎn)品：CL-0021
-
AKG induces cell apoptosis by inducing reactive oxygen species-mediated endoplasmic reticulum stress and by suppressing PI3K/AKT/mTOR-mediated autophagy in renal cell carcinoma(2022/09/16)
作者：Fan Wu, Xuexia Xie, Guoliang Li
期刊：ENVIRONMENTAL TOXICOLOGY
影響因子 ：4.500
-
Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients(2024/04/26)
作者：Lei Ren, Jinwen Liu, Qingyuan Lin
期刊：BMC GENOMICS
DOI：10.1186/s12864-024-10307-0
影響因子 ：4.400
引用產(chǎn)品：CL-0021
-
GBP2 promotes clear cell renal cell carcinoma progression through immune infiltration and regulation of PD?L1 expression via STAT1 signaling(2023/01/20)
作者：Shujiang Ye, Siyu Li, Lei Qin
期刊：ONCOLOGY REPORTS
影響因子 ：4.200
-
Dysregulated ANLN reveals immune cell landscape and promotes carcinogenesis by regulating the PI3K/Akt/mTOR pathway in clear cell renal cell carcinoma(2023/12/09)
作者：Mingzhu Gao, Zhouting Tuo, Zhiwei Jiang
期刊：Heliyon
DOI：10.1016/j.heliyon.2023.e23522
影響因子 ：4.000
引用產(chǎn)品：CL-0021
-
TNFAIP8 promotes the migration of clear cell renal cell carcinoma by regulating the EMT(2020/3/4)
作者：Mengya Zhong, Maoshu Zhu, Yu Liu
期刊：Journal of Cancer
影響因子 ：3.900
-
Tropomyosin-1 Functions as a Tumor Suppressor with Respect to Cell Proliferation, Angiogenesis and Metastasis in Renal Cell Carcinoma(2019/05/21)
作者：Jin Wang, Chao Tang, Chao Yang
期刊：Journal of Cancer
影響因子 ：3.900
-
Sodium selenite inhibits proliferation and metastasis through ROS‐mediated NF‐κB signaling in renal cell carcinoma(2022/08/09)
作者：Xiao Liu, Meng Jiang, Chenggang Pang
期刊：BMC CANCER
DOI：10.1186/s12885-022-09965-8
影響因子 ：3.800
-
The potential of Lycium barbarum miR166a in kidney cancer treatment(2022/12/28)
作者：Qiang Zhang, Zhiyuan Xie, Yan Li
期刊：EXPERIMENTAL CELL RESEARCH
DOI：10.1016/j.yexcr.2022.113455
影響因子 ：3.700
-
LINC00645 inhibits renal cell carcinoma progression by interacting with HNRNPA2B1 to regulate the ROCK1 mRNA stability(2024/02/01)
作者：Hao Li, Xu Han, Liang Song
期刊：GENE
DOI：10.1016/j.gene.2024.148232
影響因子 ：3.500
引用產(chǎn)品：CL-0021
-
Identify CTBP1-DT as an immunological biomarker that promotes lipid synthesis and apoptosis resistance in KIRC(2024/03/21)
作者：Haolin Li, Mintian Fei, Yi Zhang
期刊：GENE
DOI：10.1016/j.gene.2024.148403
影響因子 ：3.500
引用產(chǎn)品：CL-0021
-
P4HA3 promotes clear cell renal cell carcinoma progression via the PI3K/AKT/GSK3β pathway(2023/01/02)
作者：Zhechuan Zhang, Yuanfeng Zhang, Ronggui Zhang
期刊：MEDICAL ONCOLOGY
DOI：10.1007/s12032-022-01926-2
影響因子 ：3.400
-
Tropomyosin-1 promotes cancer cell apoptosis via the p53-mediated mitochondrial pathway in renal cell carcinoma(2018/3/7)
作者：Chao Tang, Jin Wang, Qi Wei
期刊：Oncology Letters
影響因子 ：2.900
-
Comprehensive Pan-Cancer Analysis of Connexin 43 as a Potential Biomarker and Therapeutic Target in Human Kidney Renal Clear Cell Carcinoma (KIRC)(2024/05/08)
作者：Huzi Xu, Xiuru Wang, Fan Zhu
期刊：Medicina-Lithuania
影響因子 ：2.600
引用產(chǎn)品：CL-0021
-
Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis(2022/09/01)
作者：Sheng Xue, Hanxu Guo, Shibo Wei
期刊：Translational Andrology and Urology
影響因子 ：2.000
-
Pachymic Acid Inhibits the Migration and Epithelial–Mesenchymal Transition of Renal Cell Carcinoma(2022/10/17)
作者：Yuanyuan Luo, Zewen Chu, Zhefeng Wang
期刊：Natural Product Communications
影響因子 ：1.800
-
Circ_0000069 contributes to the growth, metastasis and glutamine metabolism in renal cell carcinoma (RCC) via regulating miR-125a-5p-dependent SLC1A5 expression(2022/11/30)
作者：Liqing Yang, Lin Wang, Jitao Wu, Yongqiang Wang
期刊：TRANSPLANT IMMUNOLOGY
DOI：10.1016/j.trim.2022.101764
影響因子 ：1.500
FAQs
Q：{{item.question}}
A：
產(chǎn)品資料
識(shí)別碼示意圖
娜胡文君.png "邱國(guó)娜/胡文君")
.png "梅文強(qiáng)")
